Literature DB >> 23296171

Coming full circle in diabetes mellitus: from complications to initiation.

Brooke E Harcourt1, Sally A Penfold, Josephine M Forbes.   

Abstract

Glycaemic control, reduction of blood pressure using agents that block the renin-angiotensin system and control of dyslipidaemia are the major strategies used in the clinical management of patients with diabetes mellitus. Each of these approaches interrupts a number of pathological pathways, which directly contributes to the vascular complications of diabetes mellitus, including renal disease, blindness, neuropathy and cardiovascular disease. However, research published over the past few years has indicated that many of the pathological pathways important in the development of the vascular complications of diabetes mellitus are equally relevant to the initiation of diabetes mellitus itself. These pathways include insulin signalling, generation of cellular energy, post-translational modifications and redox imbalances. This Review will examine how the development of diabetes mellitus has come full circle from initiation to complications and suggests that the development of diabetes mellitus and the progression to chronic complications both require the same mechanistic triggers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296171     DOI: 10.1038/nrendo.2012.236

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  190 in total

1.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Authors:  Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

3.  Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway.

Authors:  Darren J Bridgewater; Jackie Ho; Victor Sauro; Douglas G Matsell
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

Review 4.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

5.  Insulin receptor substrate-2 is not necessary for insulin- and exercise-stimulated glucose transport in skeletal muscle.

Authors:  Y Higaki; J F Wojtaszewski; M F Hirshman; D J Withers; H Towery; M F White; L J Goodyear
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

6.  Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells.

Authors:  Luciene R Carraro-Lacroix; Gerhard Malnic; Adriana C C Girardi
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

7.  Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo.

Authors:  I G Fantus; R Brosseau
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

8.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

9.  Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance.

Authors:  N Yamada; H Yoshinaga; N Sakurai; H Shimano; T Gotoda; Y Ohashi; Y Yazaki; K Kosaka
Journal:  Diabetes Care       Date:  1994-02       Impact factor: 19.112

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  30 in total

Review 1.  PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  In vivo assessment of intracellular redox state in rat liver using hyperpolarized [1-13 C]Alanine.

Authors:  Jae Mo Park; Chalermchai Khemtong; Shie-Chau Liu; Ralph E Hurd; Daniel M Spielman
Journal:  Magn Reson Med       Date:  2017-03-05       Impact factor: 4.668

3.  Aging and Hyperglycemia Intensify Dyslipidemia-Induced Oxidative Stress and Inflammation in Rats: Assessment of Restorative Potentials of ALA and EPA + DHA.

Authors:  Pooja Acharya; Ramaprasad Ravichandra Talahalli
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

4.  Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.

Authors:  Nicole J Kellow; Melinda T Coughlan; Christopher M Reid
Journal:  Eur J Nutr       Date:  2017-06-27       Impact factor: 5.614

5.  Dysregulation of RBFOX2 Is an Early Event in Cardiac Pathogenesis of Diabetes.

Authors:  Curtis A Nutter; Elizabeth A Jaworski; Sunil K Verma; Vaibhav Deshmukh; Qiongling Wang; Olga B Botvinnik; Mario J Lozano; Ismail J Abass; Talha Ijaz; Allan R Brasier; Nisha J Garg; Xander H T Wehrens; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  Cell Rep       Date:  2016-05-26       Impact factor: 9.423

6.  Posttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon.

Authors:  Julia M Santos; Manish Mishra; Renu A Kowluru
Journal:  Exp Eye Res       Date:  2014-03-04       Impact factor: 3.467

Review 7.  Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.

Authors:  Curtis A Nutter; Muge N Kuyumcu-Martinez
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-12-27       Impact factor: 9.957

8.  CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart.

Authors:  KarryAnne Belanger; Curtis A Nutter; Jin Li; Sadia Tasnim; Peiru Liu; Peng Yu; Muge N Kuyumcu-Martinez
Journal:  Biochem Biophys Res Commun       Date:  2018-08-27       Impact factor: 3.575

9.  Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling.

Authors:  Sunil K Verma; Vaibhav Deshmukh; Patrick Liu; Curtis A Nutter; Rosario Espejo; Ming-Lung Hung; Guey-Shin Wang; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

Review 10.  The Exosome: a New Player in Diabetic Cardiomyopathy.

Authors:  Lichan Tao; Jia Shi; Xiaoyu Yang; Ling Yang; Fei Hua
Journal:  J Cardiovasc Transl Res       Date:  2018-09-24       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.